Proteomics approaches for identification of tumor relevant protein targets in pulmonary squamous cell carcinoma by 2d-dige-ms

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Lihong, Hao ^a   Linlin, Gong ^a   Yiping, Guo ^a   Yang, Song ^a   Xiaoyu, Qi ^a   Zhuzhu, Guan ^a   Xiaohan, Yang ^a   Xin, Zhou ^a   Liyan, Xue ^b   Shujuan, Shao ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; SERUM AMYLOID P; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; BIOINFORMATICS; CANCER GROWTH; CELL COMPONENT; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROSPRAY IONIZATION QUADRUPOLE TIME OF FLIGHT MASS SPECTROMETRY; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LUNG SQUAMOUS CELL CARCINOMA; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; PROTEIN TRANSPORT; PROTEOMICS; REPRODUCTION; SYSTEMS BIOLOGY; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; UNINDEXED SEQUENCE; VALIDATION STUDY; WESTERN BLOTTING; ENZYME LINKED IMMUNOSORBENT ASSAY; MASS SPECTROMETRY; PROTEIN ISOLATION; SQUAMOUS CELL LUNG CARCINOMA; STATISTICAL ANALYSIS; TIME OF FLIGHT MASS SPECTROMETRY; AMINO ACID SEQUENCE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR MICROENVIRONMENT; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; AGED; AMINO ACID SEQUENCE; CARCINOMA, SQUAMOUS CELL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; METABOLIC NETWORKS AND PATHWAYS; MIDDLE AGED; MOLECULAR SEQUENCE ANNOTATION; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MICROENVIRONMENT;

EID: 84930172656     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095121.g002     Document Type: Article

References (27)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, et al. (2007) Cancer statistics. CA Cancer J Clin 57: 43-66.
2. Maurya P, Meleady P, Dowling P, Clynes M (2007) Proteomic approaches for serum biomarker discovery in cancer. Anticancer Res 27: 1247-1255. (Pubitemid 46807270)
3. Hoorn EJ, Hoffert JD, Knepper MA. (2006) The application of DIGE-based proteomics to renal physiology. Nephron Physiol 104: 61-72.
4. Alban A, David SO, Bjorkesten L, Andersson C, Sloqe E, et al. (2003) A novel experimental design for comparative two-dimensional gel analysis: twodimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 3: 36-44. (Pubitemid 36151066)
5. Marouga R, David S, Hawkins E (2005) The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal Bioanal Chem 382:669-678. (Pubitemid 40890994)
6. Zhang XZ, Xiao ZF, Li C, Xiao ZQ, et al. (2009) Triosephosphate isomerase and peroxiredoxin 6, two novel serum markers for human lung squamous cell carcinoma. Cancer Sci 100: 2396-2401.
7. Rho JH, Roehrl MH, Wang JY (2009) Glycoproteomic Analysis of Human Lung Adenocarcinomas Using Glycoarrays and Tandem Mass Spectrometry: Differential Expression and Glycosylation Patterns of Vimentin and Fetuin A Isoforms. Protein J 28: 148-160.
8. Poschmann G, Sitek B, Sipos B, Ulrich A, Wiese S, et al. (2009) Identification of Proteomic Differences between Squamous Cell Carcinoma of the Lung and Bronchial Epithelium. Mol Cell Proteomics 8: 1105-1116.
9. Yao H, Zhang Z, Xiao Z, Chen Y, Li C, et al. (2009) Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection. Lung Cancer 65: 41-48.
10. Wittekind C, Compton CC, Greene FL, Sobin LH (2002) TNM residual tumor classification revisited. Cancer 94: 2511-2516. (Pubitemid 34457134)
11. Fuhrman SA, Lasky LC, Limas C. (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6: 655-663. (Pubitemid 13234762)
12. Yu LR, Zeng R, Shao XX, Wang N, Xu YH, et al. (2000) Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by 2 dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry. Electrophoresis 21: 3058-3068.
13. Patel PS, Telang SD, Rawal RM, Shah MH (2005) A review of proteomics in cancer research. Asian Pac J Cancer Prev 6: 113-117.
14. Mi H, Lazareva-Ulitsky B, Loo R, Kejariwal A, Vanderqriff J, et al. (2005) PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res 33 (Database issue): D284-288. (Pubitemid 40207879)
15. Warburg O (1956) On the origin of cancer cells. Science 123: 309-314.
16. Grundy SM, Vega GL (1990) Role of Apolipoprotein Levels in Clinical Practice. Arch Int Med 8: 1579-1582. (Pubitemid 20240967)
17. Dessí S, Batetta B, Pulisci D, Spano O, Anchisi C, et al. (1994) Cholesterol content in tumor tissues is inversely associated with high density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer 73: 253-258. (Pubitemid 24030598)
18. Jang JS, Cho HY, Lee YJ, Ha WS, Kim HW (2004) The differential proteome profile of stomach cancer: identification of the biomarker candidates. Oncol Res 14: 491-499. (Pubitemid 39551562)
19. Gao YH, Zhang Y, Tian YP, Xiang R. (2010) Analysis of Serum Lipid Levels in Patients with Cancer. Labeled Immunoassays and Clinical Medicine 17: 277-280.
20. Rong JX, Li J, Reis ED, Choudhury RP, Dansky HM, et al. (2001) Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content. Circulation 104: 2447-2452. (Pubitemid 33108379)
21. Zahedi K (1997) Characterization of the binding of serum amyloid P to laminin. J Biol Chem 272: 2143-2148. (Pubitemid 27058492)
22. Auguste P, Lemiere S, Larrieu-Lahargue F, Bikfalvi A (2005). Molecular mechanisms of tumor vascularization. Crit Rev Oncol Hematol 54: 53-61. (Pubitemid 40387005)
23. Oram JF, Johnson CJ, Brown TA. (1987) Interaction of high density lipoprotein with its receptor on cultured fibroblasts and macrophages. Evidence for reversible binding at the cell surface without internalization. J Biol Chem 262:2405-2410.
24. Shen L, Zhu X, Wang Y, Zeng W, Wu G, et al. (2008) Secreted human apolipoprotein (a) kringle IV-10 and kringle V inhibit angiogenesis and xenografted tumor growth. Biol Chem 389: 135-141. (Pubitemid 351170662)
25. Yi ZF, Cho SG, Zhao H, Wu YY, Luo J, et al. (2009) A novel peptide from human apolipoprotein (a) inhibits angiogenesis and tumor growth by targeting c- Src phosphorylation in VEGF-induced human umbilical endothelial cells. Int J Cancer 124: 843-852.
26. Chatterji B, Borlak J (2009) A 2-DE MALDI-TOF study to identify disease regulated serum proteins in lung cancer of c-myc transgenic mice. Proteomics 9:1044-1056.
27. Park SY, Phark S, Lee M, Zheng Z, Choi S, et al. (2010) Evaluation of plasma carcinogenic markers in rat hepatic tumors models induced by rat hepatoma N1- S1 cells and benzo[a]pyrene. Arch Pharm Res 33: 247-255.